Free press releases distribution network?

Agency / Source: ZOLL Medical Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Circulation 62% More Likely to Return with ZOLL AutoPulse - Clinical Benefits Unmatched by Other Mechanical CPR Systems - /
Circulation 62% More Likely to Return with ZOLL AutoPulse


PRZOOM - /newswire/ - Chelmsford, MA, United States, 2013/06/06 - Clinical Benefits Unmatched by Other Mechanical CPR Systems - / NASDAQ: ZOLL

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that a paper just published in Critical Care Medicine reported the likelihood of achieving a return of spontaneous circulation (ROSC) after sudden cardiac arrest (SCA) is 62% greater when the AutoPulse® Non-invasive Cardiac Support Pump is used to deliver CPR chest compressions.

The paper is a meta-analysis of changes to ROSC rates from 12 previously published human studies that compared the use of manual and mechanically delivered chest compressions during out-of-hospital cardiac arrests (OHCA). Collectively these studies included 6,538 patients. The analysis showed use of the AutoPulse, which delivers circumferential compressions with a load-distributing band, was 62% more likely to produce ROSC. In contrast the analysis demonstrated that a piston-driven, sternal compression technology had no incremental impact on ROSC rates.

Commenting on the paper, lead author Mark Westfall, DO, FACEP, FACP, Theda Clark Regional Medical Center, Neenah, Wis., said,“This analysis contributes greatly to our understanding of the impact mechanical CPR systems have in the pre-hospital setting. The use of ROSC as a primary endpoint is most appropriate in this environment. Whereas survival is an endpoint influenced by a variety of factors that aren’t necessarily related to the quality of CPR performed in the field, the ability to achieve ROSC in the pre-hospital setting is closely linked to the delivery of high-quality chest compressions.”

“This is the first paper that looks at the efficacy of multiple mechanical CPR technologies,” said Jonathan A. Rennert, President of ZOLL. “The analysis produced two major findings. First, it showed a 62% greater likelihood of achieving ROSC with the AutoPulse, while a parallel analysis showed no change in ROSC when a piston-driven device was used to provide chest compressions. Secondly, the analysis confirms expert opinion that findings from one mechanical CPR technology cannot be applied to another.”

The AutoPulse is the only mechanical CPR system to have shown improved survival in comparative clinical trials. The AutoPulse more than tripled survival compared to typical CPR during witnessed shockable arrests1. It uses the load-distributing LifeBand® to deliver unprecedented circulation by squeezing the entire chest to improve blood flow to a patient’s heart and brain during sudden cardiac arrest. The AutoPulse delivers high-quality, uninterrupted CPR chest compressions to maintain myocardial and cerebral perfusion.

Cardiac arrest is a substantial public health problem killing approximately 325,000 persons each year in the U.S. and Canada alone and as many as a million worldwide. Survival is poor in most communities at less than eight percent, and improvements in resuscitation practices could save as many as half of these victims.

About ZOLL Medical Corporation

ZOLL Medical Corporation (, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

About Asahi Kasei

The Asahi Kasei Group ( is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 25,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.

Copyright © 2013 ZOLL Medical Corporation. All rights reserved. AutoPulse, LifeBand, and ZOLL are trademarks and/or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All trademarks are the property of their respective owners.

1Wik L, et al. The impact of CPR duration on survival to discharge between integrated AutoPulse-CPR and manual CPR during out-of-hospital cardiac arrest of presumed cardiac origin. Resuscitation. 2012;83:e17

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: ZOLL Medical Corporation


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!

Circulation 62% More Likely to Return with ZOLL AutoPulse

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Contact: Diane Egan - 
978-421-9637 degan[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ZOLL Medical Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Press Releases From ZOLL Medical Corporation / Company Profile

Read Medical Services/Equipment Most Recent Related Press Releases:

Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing
GE Healthcare’s Biosafe Announces Sefia Platform to Address Multiple Steps in Cell Therapy Production Process

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



Visit  Intrinsic Executive Search Ltd

Visit  MagLar, Inc.

  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today